New research found women on bisphosphonate therapy who take a drug holiday experience a higher rate of hip fracture…

New research found women on bisphosphonate therapy who take a drug holiday experience a higher rate of hip fracture…
In a Year in Review session at the 2017 ACR/ARHP Annual Meeting, Daniel Solomon, MD, MPH, highlighted the latest and most intriguing aspects of clinical research on rheumatic diseases from 2017. His discussion touched on medical therapy, genetics, the effects of bariatric surgery and diet, cancer risk and more…
New data shows that both private and public rheumatology practices benefit financially by hiring non-physician providers (NPPs). But when should practices hire NPPs?
For the last 20 years, Philip Seo, MD MHS, has trained, worked and conducted research at Johns Hopkins University. As an associate professor of medicine, he also serves in two other roles: as the director of the university’s fellowship training program and director of its vasculitis center. After graduating medical school from Columbia University in…
Beginning in April 2018, Medicare patients will receive newly designed Medicare identification cards that replace their Social Security numbers (SSNs) with unique, randomly assigned, alphanumeric identification numbers. The Centers for Medicare & Medicaid Services (CMS) is making the change to protect patients 65 and older from exposing their SSNs in efforts to “help prevent fraud,…
The FDA has expanded the indications for golimumab, an anti-TNF-alpha monoclonal antibody, to include the treatment of active psoriatic arthritis and ankylosing spondylitis…
Rosemarie A. Curley, MPT, DPT |
Raynaud’s phenomenon in scleroderma or systemic sclerosis (SSc) is associated with significant discomfort and functional disability, especially in the presence of digital ulcers.1 Having lived with diffuse systemic sclerosis (dSSc) for nearly a decade, I can attest to this. It has been my experience that the hand pain and dysfunction in dSSc stems from Raynaud’s…
Roughly 15 years ago, Steven K. Magid, MD, rheumatologist and chief medical information officer at the Hospital for Special Surgery (HSS) in N.Y., attended a social event for hospital employees. While chatting with other physicians, nurses, and lab techs, he watched one of his colleagues slaughter her opponents at Ping-Pong. “She was very skilled,” recalls Dr. Magid,…
Medications for serious or life-threatening conditions may receive accelerated approval from the U.S. Food and Drug Administration (FDA) by showing an effect on surrogate measures that are reasonably likely to predict a treatment’s clinical benefit. Post-approval confirmatory drug trials are then required to determine whether or not these effects translate into clinical improvements. In recent…
RETRACTED Editor’s note: The study this article reported on was retracted by the researchers. Key aspects could not be replicated, and they said, “Most importantly, the findings from behaviour studies and sequencing of microglia isolated from 564Igi autoimmune mice as shown in Figs. 1a, b, d and 3a, b are not substantiated upon further analysis…